These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 12937153)
1. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Davenport P; Tipping PG Am J Pathol; 2003 Sep; 163(3):1117-25. PubMed ID: 12937153 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications. Chi H; Messas E; Levine RA; Graves DT; Amar S Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494 [TBL] [Abstract][Full Text] [Related]
4. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027 [TBL] [Abstract][Full Text] [Related]
5. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Kirii H; Niwa T; Yamada Y; Wada H; Saito K; Iwakura Y; Asano M; Moriwaki H; Seishima M Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):656-60. PubMed ID: 12615675 [TBL] [Abstract][Full Text] [Related]
6. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. Zhou X; Paulsson G; Stemme S; Hansson GK J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503 [TBL] [Abstract][Full Text] [Related]
7. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Schieffer B; Selle T; Hilfiker A; Hilfiker-Kleiner D; Grote K; Tietge UJ; Trautwein C; Luchtefeld M; Schmittkamp C; Heeneman S; Daemen MJ; Drexler H Circulation; 2004 Nov; 110(22):3493-500. PubMed ID: 15557373 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098 [TBL] [Abstract][Full Text] [Related]
10. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Mallat Z; Gojova A; Brun V; Esposito B; Fournier N; Cottrez F; Tedgui A; Groux H Circulation; 2003 Sep; 108(10):1232-7. PubMed ID: 12912803 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Zhou X; Stemme S; Hansson GK Am J Pathol; 1996 Aug; 149(2):359-66. PubMed ID: 8701976 [TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin-15 in mouse and human atherosclerotic lesions. Wuttge DM; Eriksson P; Sirsjö A; Hansson GK; Stemme S Am J Pathol; 2001 Aug; 159(2):417-23. PubMed ID: 11485899 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123 [TBL] [Abstract][Full Text] [Related]
15. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice. Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561 [TBL] [Abstract][Full Text] [Related]
16. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development. Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908 [TBL] [Abstract][Full Text] [Related]
17. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide. Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811 [TBL] [Abstract][Full Text] [Related]
18. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564 [TBL] [Abstract][Full Text] [Related]
19. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. Daugherty A; Puré E; Delfel-Butteiger D; Chen S; Leferovich J; Roselaar SE; Rader DJ J Clin Invest; 1997 Sep; 100(6):1575-80. PubMed ID: 9294126 [TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice. Yoshioka T; Okada T; Maeda Y; Ikeda U; Shimpo M; Nomoto T; Takeuchi K; Nonaka-Sarukawa M; Ito T; Takahashi M; Matsushita T; Mizukami H; Hanazono Y; Kume A; Ookawara S; Kawano M; Ishibashi S; Shimada K; Ozawa K Gene Ther; 2004 Dec; 11(24):1772-9. PubMed ID: 15496963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]